Immunogenicity, antigenicity and mechanisms of tumor rejection of mineral-oil-induced plasmacytomas in syngeneic BALB/c mice.
D000814:Aniline Compounds; D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D003165:Complement System Proteins; D003429:Cross Reactions; D000939:Epitopes; D005260:Female; D005354:Fibrosarcoma / Q000276:immunology; D006084:Graft Rejection; D006649:Histocompatibility Antigens / Q000032:analysis; D007518:Isoantibodies; D007942:Leukemia, Experimental / Q000139:chemically induced; D008213:Lymphocyte Activation; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008979:Moloney murine leukemia virus / Q000276:immunology; D009150:Mustard Compounds; D009368:Neoplasm Transplantation; D010954:Plasmacytoma / Q000276:immunology*; D012513:Sarcoma, Experimental / Q000139:chemically induced; D013539:Simian virus 40 / Q000276:immunology; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes
D000814:Aniline Compounds; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D000939:Epitopes; D006649:Histocompatibility Antigens; D007518:Isoantibodies; D009150:Mustard Compounds; D003165:Complement System Proteins